Furthermore, this study showed that CD4+ T cell neo-epitope vaccination induced CD8+ CTL responses against an independent tumor antigen in the vaccinated mice, possibly due to the occurrence of an “antigenic spread” in the vaccinated mice [100]. The gene discussed is CD4; the disease is neoplasm.